Orasure Technologies Inc (OSUR)

10:03 AM

OraSure in pact for celiac disease testing (OSUR:NASDAQ) - Seeking Alpha

10:03 AM

08:52 AM

OraSure Technologies (OSUR) Partners to Enhance At-Home Celiac Testing | OSUR Stock News - GuruFocus

08:52 AM

08:07 AM

Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing - The Manila Times

08:07 AM

May 10, 2025

Orasure technologies outlines Q2 2025 revenue guidance of $28.5M-$32.5M amid new product launches and customer expansions - MSN

May 10, 2025

May 10, 2025

OraSure Executive Resigns, Effective June 30 - Investing.com

May 10, 2025

May 09, 2025

OraSure Executive Resigns, Effective June 30 By Investing.com - Investing.com Canada

May 09, 2025

May 09, 2025

OraSure Technologies First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 09, 2025

May 09, 2025

OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2025 Earnings Call Transcript - Insider Monkey

May 09, 2025

May 09, 2025

OraSure Technologies Announces CPO Resignation - TipRanks

May 09, 2025

May 09, 2025

Orasure Technologies, Inc. Announces Resignation of Chief Product Officer Kathleen G. Weber Effective June 30, 2025 - marketscreener.com

May 09, 2025

May 08, 2025

Evercore ISI cuts OraSure stock price target to $3 from $4 - Investing.com Nigeria

May 08, 2025

May 08, 2025

Shareholders Will Probably Hold Off On Increasing OraSure Technologies, Inc.'s (NASDAQ:OSUR) CEO Compensation For The Time Being - simplywall.st

May 08, 2025

May 08, 2025

OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance

May 08, 2025

May 08, 2025

OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth - GuruFocus

May 08, 2025

May 08, 2025

Earnings call transcript: OraSure’s Q1 2025 beats EPS forecast, stock stable - Investing.com

May 08, 2025

May 08, 2025

OraSure Technologies Reports Q1 2025 Financial Results - TipRanks

May 08, 2025

May 07, 2025

OraSure: Q1 Earnings Snapshot - The Washington Post

May 07, 2025

May 07, 2025

OraSure reports first quarter loss, but looks forward to emerging as 'stronger enterprise' - WFMZ.com

May 07, 2025

May 07, 2025

OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 07, 2025

May 07, 2025

OraSure Technologies (OSUR) Projects Q2 2025 Revenue Growth | OS - GuruFocus

May 07, 2025

May 07, 2025

OraSure Technologies Reports Q1 2025 Revenue Decline - TipRanks

May 07, 2025

May 07, 2025

OraSure Technologies (OSUR) Projects Q2 2025 Revenue Growth | OSUR Stock News - GuruFocus

May 07, 2025

May 07, 2025

OraSure (OSUR) Reports Q1 Revenue Slightly Above Expectations | OSUR Stock News - GuruFocus

May 07, 2025

May 07, 2025

OraSure Announces First Quarter 2025 Financial Results - The Manila Times

May 07, 2025

May 05, 2025

OraSure Technologies Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView

May 05, 2025

Apr 30, 2025

OraSure Technologies: Historically Cheap (NASDAQ:OSUR) - Seeking Alpha

Apr 30, 2025

Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Apr 23, 2025

OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th - The Manila Times

Apr 23, 2025

Apr 23, 2025

OraSure Technologies, Inc. Schedules Q1 2025 Earnings Conference Call for May 7, 2025 - Nasdaq

Apr 23, 2025

Apr 23, 2025

OraSure Q1 2025 Earnings Preview: Key Financial Metrics and Live Q&A Session Coming May 7 - Stock Titan

Apr 23, 2025

Apr 22, 2025

Your Guide to Rapid Testing for Syphilis, HIV & HCV - Labroots

Apr 22, 2025

Apr 15, 2025

OraSure Technologies to Present at CL King’s 15th Annual Best Ideas Conference - marketscreener.com

Apr 15, 2025

Apr 10, 2025

GE HealthCare (GEHC) Surges 10.6%: Is This an Indication of Further Gains? - Nasdaq

Apr 10, 2025

Apr 10, 2025

Premier Biotech Increases Offerings and Global Distribution Network with Recent Acquisitions - The Joplin Globe

Apr 10, 2025

Apr 09, 2025

Drug Screening Market is Expected to Reach $19.5 billion | MarketsandMarkets™ - The Globe and Mail

Apr 09, 2025

Apr 09, 2025

OraSure Technologies (NASDAQ:OSUR shareholders incur further losses as stock declines 12% this week, taking five-year losses to 75% - Yahoo Finance

Apr 09, 2025

Apr 09, 2025

Insider Stock Buying Reaches US$761.0k On OraSure Technologies - simplywall.st

Apr 09, 2025

Apr 06, 2025

OraSure Technologies Elects Jack Kenny to the Board of Directors - marketscreener.com

Apr 06, 2025

Apr 02, 2025

OraSure Technologies, Inc. (OSUR): Insider Were Buying In Q1 2025 - Insider Monkey

Apr 02, 2025

Apr 01, 2025

OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Sold by Charles Schwab Investment Management Inc. - MarketBeat

Apr 01, 2025

Mar 25, 2025

OraSure announces $40M stock buy back - Lehigh Valley Business

Mar 25, 2025

Mar 24, 2025

OraSure announces $40 million stock buyback plan By Investing.com - Investing.com Australia

Mar 24, 2025

Mar 24, 2025

OraSure announces $40 million stock repurchase program - WFMZ.com

Mar 24, 2025